Header Logo

Connection

Wei Wang to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Wei Wang has written about Carcinoma, Hepatocellular.
Wei Wang
Connection Strength
0.661
Carcinoma, Hepatocellular
  1. MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53. Cancer Lett. 2019 09 10; 459:156-167.
    View in: PubMed
    Score: 0.661
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.